Cardinal Health, Inc.
CAH
Classifica tra le azioni
#410
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Prezzo delle azioni
$253.84
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$58.78B
Variazione (1 giorno)
0.21%
Variazione (1 anno)
62.29%
Paese
US
Scambia Cardinal Health, Inc. (CAH)
Categoria
Healthcare
Margine operativo per Cardinal Health, Inc. (CAH)
Margine operativo al October 2026 TTM: 1.03%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cardinal Health, Inc., il margine operativo attuale (TTM) è 1.03%. Alla fine del 2024, il margine operativo era 0.55%.
Storico del margine operativo per Cardinal Health, Inc. da 2000 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 1.03% | 0.98% |
| 2025 | 1.02% | 85.45% |
| 2024 | 0.55% | 48.65% |
| 2023 | 0.37% | -212.12% |
| 2022 | -0.33% | -213.79% |
| 2021 | 0.29% | -110.82% |
| 2020 | -2.68% | -288.73% |
| 2019 | 1.42% | 1,477.78% |
| 2018 | 0.09% | -94.48% |
| 2017 | 1.63% | -19.31% |
| 2016 | 2.02% | -4.27% |
| 2015 | 2.11% | 1.93% |
| 2014 | 2.07% | 109.09% |
| 2013 | 0.99% | -40.72% |
| 2012 | 1.67% | 12.84% |
| 2011 | 1.48% | 11.28% |
| 2010 | 1.33% | -0.75% |
| 2009 | 1.34% | -15.72% |
| 2008 | 1.59% | 0.63% |
| 2007 | 1.58% | -31.90% |
| 2006 | 2.32% | -5.31% |
| 2005 | 2.45% | -32.13% |
| 2004 | 3.61% | -6.48% |
| 2003 | 3.86% | 7.52% |
| 2002 | 3.59% | 15.81% |
| 2001 | 3.10% | -7.19% |
| 2000 | 3.34% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 1.62% | -98.43% |
US
|
|
| 0.00% | - |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -91.06% |
AU
|
|
| 5.69% | -94.48% |
US
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.